S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
S&P 500   4,320.06
DOW   33,963.84
QQQ   357.91
MILAN FASHION PHOTOS: Naomi Campbell stuns at Dolce&Gabbana in collection highlighting lingerie
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Minnesota's would-be head of cannabis regulation quits amid reports she sold illegal products
High-speed rail was touted as a game-changer in Britain. Costs are making the government think twice
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
After climate summit, California Gov. Gavin Newsom faces key decisions to reduce emissions back home
The threat of wildfires is rising. So are new artificial intelligence solutions to fight them
Wall Street Insider Makes Prediction about Hot A.I. Stock (Ad)
Giorgio Armani closes Milan Fashion Week with good vibes and familiar guests in the front row
Canadian autoworkers ratify new labor agreement with Ford
NASDAQ:INGN

Inogen (INGN) Stock Forecast, Price & News

$5.21
+0.06 (+1.17%)
(As of 09/22/2023 ET)
Compare
Today's Range
$5.14
$5.29
50-Day Range
$5.15
$9.11
52-Week Range
$5.05
$26.11
Volume
320,197 shs
Average Volume
210,814 shs
Market Capitalization
$120.82 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$14.00

Inogen MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
168.7% Upside
$14.00 Price Target
Short Interest
Healthy
2.13% of Shares Sold Short
Dividend Strength
N/A
Sustainability
-1.12
Upright™ Environmental Score
News Sentiment
0.26mentions of Inogen in the last 14 days
Based on 5 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($2.35) to ($2.18) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.18 out of 5 stars

Medical Sector

403rd out of 963 stocks

Surgical Appliances & Supplies Industry

10th out of 18 stocks


INGN stock logo

About Inogen (NASDAQ:INGN) Stock

Inogen, Inc., a medical technology company, develops, manufactures, and markets portable oxygen concentrators to patients, physicians and other clinicians, and third-party payors in the United States and internationally. Its oxygen concentrators are used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. The company offers Inogen One, a portable device that concentrate the air around the patient to provide a single source of supplemental oxygen; Inogen At Home stationary oxygen concentrators; and related accessories. The company also rents its products directly to patients. Inogen, Inc. was incorporated in 2001 and is headquartered in Goleta, California.

INGN Price History

INGN Stock News Headlines

Inogen, Inc. (NASDAQ:INGN) Sees Significant Growth in Short Interest
Buy This Stock for AI Tidal Wave (not NVDA)
The internet boom made more millionaires than any tech  - Microsoft’s CEO says AI has even more potential. Here’s the #1 stock to buy.
Inogen Closes Acquisition Of Physio-Assist SAS
Inogen Completes Acquisition of Physio-Assist
JP Morgan Downgrades Inogen (INGN)
His system isolated NVIDIA - Here's His Next Buy.
Most investors don't know the truth about A.I. 50-year Wall Street Insider Marc Chaikin reveals what you should be doing to profit. Learn more here.
Inogen: Q2 Earnings Snapshot
Earnings Preview For Inogen
Inogen (NASDAQ: INGN)
Will the Current Downturn Affect Inogen (INGN)?
See More Headlines
Receive INGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inogen and its competitors with MarketBeat's FREE daily newsletter.

INGN Company Calendar

Last Earnings
8/07/2023
Today
9/24/2023
Next Earnings (Estimated)
11/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:INGN
Fax
N/A
Employees
1,026
Year Founded
2001

Price Target and Rating

Average Stock Price Forecast
$14.00
High Stock Price Forecast
$26.00
Low Stock Price Forecast
$8.00
Forecasted Upside/Downside
+168.7%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
4 Analysts

Profitability

Net Income
$-83,770,000.00
Pretax Margin
-27.44%

Debt

Sales & Book Value

Annual Sales
$377.24 million
Book Value
$12.98 per share

Miscellaneous

Free Float
23,046,000
Market Cap
$120.82 million
Optionable
Optionable
Beta
0.98

Social Links

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Nabil Shabshab (Age 58)
    CEO, Pres & Director
    Comp: $943k
  • Mr. Michael K. Sergesketter (Age 63)
    Interim Exec. VP, Chief Financial Officer & Treasurer
    Comp: $227.53k
  • Dr. Stanislav Glezer M.D. (Age 50)
    MBA, Exec. VP & CTO
    Comp: $575.8k
  • Mr. Jason Somer (Age 55)
    Exec. VP, Gen. Counsel & Corp. Sec.
    Comp: $409.92k
  • Ms. Jennifer Yi Boyer
    Exec. VP & Chief HR Officer
  • Mr. Vijay Paliwal
    Sr. VP of Enterprise Enablement
  • Mr. Matthew Pigeon
    Investor Relations Officer













INGN Stock - Frequently Asked Questions

Should I buy or sell Inogen stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Inogen in the last twelve months. There are currently 4 hold ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" INGN shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in INGN, but not buy additional shares or sell existing shares.
View INGN analyst ratings
or view top-rated stocks.

What is Inogen's stock price forecast for 2023?

4 Wall Street research analysts have issued 12-month price targets for Inogen's shares. Their INGN share price forecasts range from $8.00 to $26.00. On average, they expect the company's share price to reach $14.00 in the next twelve months. This suggests a possible upside of 168.7% from the stock's current price.
View analysts price targets for INGN
or view top-rated stocks among Wall Street analysts.

How have INGN shares performed in 2023?

Inogen's stock was trading at $19.71 at the beginning of the year. Since then, INGN stock has decreased by 73.6% and is now trading at $5.21.
View the best growth stocks for 2023 here
.

Are investors shorting Inogen?

Inogen saw a increase in short interest in August. As of August 31st, there was short interest totaling 492,900 shares, an increase of 7.3% from the August 15th total of 459,300 shares. Based on an average trading volume of 400,500 shares, the short-interest ratio is currently 1.2 days.
View Inogen's Short Interest
.

When is Inogen's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, November 1st 2023.
View our INGN earnings forecast
.

How were Inogen's earnings last quarter?

Inogen, Inc. (NASDAQ:INGN) announced its earnings results on Monday, August, 7th. The medical technology company reported ($0.42) EPS for the quarter, topping analysts' consensus estimates of ($0.64) by $0.22. The medical technology company had revenue of $83.64 million for the quarter, compared to analyst estimates of $92.20 million. Inogen had a negative trailing twelve-month return on equity of 14.95% and a negative net margin of 27.57%. The business's revenue for the quarter was down 19.1% compared to the same quarter last year. During the same quarter in the prior year, the company posted ($0.02) EPS.

What guidance has Inogen issued on next quarter's earnings?

Inogen updated its FY 2023 earnings guidance on Monday, August, 7th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $315.00 million-$320.00 million, compared to the consensus revenue estimate of $369.22 million.

What is Scott Wilkinson's approval rating as Inogen's CEO?

70 employees have rated Inogen Chief Executive Officer Scott Wilkinson on Glassdoor.com. Scott Wilkinson has an approval rating of 46% among the company's employees. This puts Scott Wilkinson in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inogen own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inogen investors own include Puma Biotechnology (PBYI), BioMarin Pharmaceutical (BMRN), Incyte (INCY), (MDVN) (MDVN), NVIDIA (NVDA), Alibaba Group (BABA), Advanced Micro Devices (AMD), First Solar (FSLR), Intel (INTC) and Netflix (NFLX).

What is Inogen's stock symbol?

Inogen trades on the NASDAQ under the ticker symbol "INGN."

Who are Inogen's major shareholders?

Inogen's stock is owned by a number of retail and institutional investors. Top institutional shareholders include BlackRock Inc. (7.46%), Camber Capital Management LP (4.96%), Dimensional Fund Advisors LP (2.41%), Meros Investment Management LP (2.21%), Geode Capital Management LLC (2.02%) and State Street Corp (1.89%). Insiders that own company stock include Alison Bauerlein, Brenton Taylor, Byron Myers, Holdings A/S Novo, Ray Benjamin M Anderson and Raymond Huggenberger.
View institutional ownership trends
.

How do I buy shares of Inogen?

Shares of INGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Inogen's stock price today?

One share of INGN stock can currently be purchased for approximately $5.21.

How much money does Inogen make?

Inogen (NASDAQ:INGN) has a market capitalization of $120.82 million and generates $377.24 million in revenue each year. The medical technology company earns $-83,770,000.00 in net income (profit) each year or ($4.19) on an earnings per share basis.

How many employees does Inogen have?

The company employs 1,026 workers across the globe.

How can I contact Inogen?

Inogen's mailing address is 326 BOLLAY DRIVE, GOLETA CA, 93117. The official website for the company is www.inogen.com. The medical technology company can be reached via phone at (805) 562-0500 or via email at mpigeon@inogen.net.

This page (NASDAQ:INGN) was last updated on 9/24/2023 by MarketBeat.com Staff

My Account -